Novartis AG (Swiss: NOVN)
Lichtstrasse 35
CH-4056 Basel, Switzerland (Map) Phone: +41-61-324-1111
Fax: +41-61-324-8001
Primary US Office:
Subscribers Only http://www.novartis.com
CH-4056 Basel, Switzerland (Map) Phone: +41-61-324-1111
Fax: +41-61-324-8001
Primary US Office:
Subscribers Only http://www.novartis.com
Basic Financial Information (NOVN)
Annual Income Statements (NOVN)
All amounts in millions of British Pounds except share amounts
| Year | Revenue | Gross Profit | Operating Income | Total Net Income | Diluted EPS (Net Income) |
|---|---|---|---|---|---|
| Dec 08 | 29,408.5 | 21,508.7 | 6,760.3 | 8,233.0 | 2.48 |
| Dec 07 | 19,500.8 | 13,977.0 | 3,867.4 | 11,968.0 | 2.57 |
| Dec 06 | 18,756.7 | 13,500.1 | 4,372.6 | 7,202.0 | 1.55 |
- Income Statement, Balance Sheet, and Cash Flow
Quarterly Income Statements (NOVN)
All amounts in millions of British Pounds except share amounts
| Year | Revenue | Gross Profit | Operating Income | Total Net Income | Diluted EPS (Net Income) |
|---|---|---|---|---|---|
| Jun 09 | 6,502.1 | 4,792.8 | 1,561.1 | 2,044.0 | 0.54 |
| Mar 09 | 6,983.9 | 5,165.1 | 1,676.0 | 1,975.0 | 0.61 |
| Mar 09* | 6,983.9 | 5,165.1 | 1,676.0 | 1,975.0 | 0.61 |
| Dec 08 | 7,146.3 | 5,189.2 | 1,267.3 | 1,549.0 | 0.47 |
| Sep 08 | 6,068.7 | 4,406.6 | 1,384.3 | 2,101.0 | 0.51 |
* Irregular reporting interval
View more detailed Quarterly Financials, including:- Income Statement, Balance Sheet, and Cash Flow
Stock Quote & Chart (F)
| Date & Time | 11/27/09 13:02:57 EST |
|---|---|
| Price | $55.38 NYSE |
| Change |
 (0.47) |
| %Change |
(0.84)
%
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Comparison To Industry & Market (NOVN)
| Valuation | Company | Industry1 | Market2 |
|---|---|---|---|
| Price/Sales Ratio | 2.87 | 2.69 | 7.09 |
| Price/Earnings Ratio | 15.90 | 17.06 | 25.77 |
| Price/Book Ratio | 2.26 | 2.93 | 6.82 |
| Price/Cash Flow Ratio | 11.10 | 10.31 | 44.05 |
- 1Industry: Drug Manufacturers - Major
- 2Market: Public companies trading on the NYSE, AMEX, and NASDAQ
- Side-by-side comparison of Novartis and its top 3 competitors
Top Competitors (NOVN)
| Novartis | Johnson & Johnson | Merck | Pfizer | |
|---|---|---|---|---|
| Annual Sales | 25,886.8 | 38,751.8 | 11,247.4 | 29,359.1 |
| Employees | 96,717 | 118,700 | 51,000 | 81,800 |
| Market Cap (£ mil.) | 73,354.6 | 104,509.9 | 28,049.8 | 0.0 |
- Side-by-side comparisons of profitability, operations, and per share data
